|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Jun 30, 2022
|
Q4 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Accounts receivable, net | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Note receivable from Kantaro | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Right-of-use asset | ||||||||
| Investment in VericiDx | ||||||||
| Investment in Kantaro | ||||||||
| Other assets, net | ||||||||
| Total assets | ||||||||
| Liabilities and Shareholders' Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | ||||||||
| Related Party | ||||||||
| Nonrelated Party | ||||||||
| Total accounts payable | ||||||||
| Accounts payable - related party | ||||||||
| Accrued expenses and other current liabilities | ||||||||
| Accrued expenses - related party | ||||||||
| Deferred revenue | ||||||||
| Current lease liability | ||||||||
| Convertible notes-current | ||||||||
| Payable to affiliate - current | ||||||||
| Total current liabilities | ||||||||
| Convertible notes-noncurrent | ||||||||
| Noncurrent lease liability | ||||||||
| Total liabilities | ||||||||
| Shareholders' deficit: | ||||||||
| Ordinary shares, 0.0025 par value per share: 173,841,695 shares authorized; 165,925,513 and 154,368,191 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Accumulated deficit | ||||||||
| Total shareholders' deficit | ||||||||
| Total liabilities and shareholders' deficit | ||||||||
Loading...
